GSK Consumer Q3 net up 20%
The company had reported a net profit of Rs 136.4 crore for the October-December period a year ago. The company’s revenue from operations was Rs 1,034.7 crore.
By PTI |
ThinkStock Photos
NEW DELHI: GlaxoSmithKline Consumer Healthcare on Monday reported a 20% increase in its standalone net profit at Rs 163.7 crore for the quarter ended December 2017, on the back of a strong performance by its flagship health drink brands — Horlicks and Boost.
The company had reported a net profit of Rs 136.4 crore for the October-December period a year ago. The company’s revenue from operations was Rs 1,034.7 crore.
It was Rs 960.2 crore in the year-ago period, GlaxoSmithKline Consumer Healthcare said in a BSE filing. “We have delivered a strong third quarter owing to robust performances by Horlicks and Boost,” GSK MD Navneet Saluja said.
The company had reported a net profit of Rs 136.4 crore for the October-December period a year ago. The company’s revenue from operations was Rs 1,034.7 crore.
It was Rs 960.2 crore in the year-ago period, GlaxoSmithKline Consumer Healthcare said in a BSE filing. “We have delivered a strong third quarter owing to robust performances by Horlicks and Boost,” GSK MD Navneet Saluja said.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Hindustan Unilever-GSK Consumer to terminate distribution agreement for OTC products by next yearADVERTISEMENT
